Allos Pharma
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.allospharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Allos Pharma
Allos Pharma is a late-stage pharmaceutical company focused on developing targeted therapeutics for Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). Their lead product, arbaclofen, aims to correct the underlying molecular pathophysiology of these neurodevelopmental disorders, demonstrating clinically meaningful improvements in social functioning and irritability. The company leverages decades of translational neuroscience and clinical experience to advance its pipeline of therapeutics. Allos Pharma is dedicated to delivering science-based treatments for underserved neurodevelopmental and neurological disorders.Explore more
Allos Pharma Org Chart
SB
Director, Medical Writing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allos Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Allos Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Allos Pharma is spiking on competitors!
Allos Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Allos Pharma recently announced quarterly report
Product Launch: Get notified when Allos Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Allos Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Allos Pharma
Funding: Get notified immidiatlly once Allos Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Allos Pharma
Compare insights from companies similar to Allos Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Allos Pharma
<$5M
1-10
Private
-
2019
KW
Karen Walton-BowenClinical Operations, Biostatistical Analysis & Reporting Head
Company Profile Activity
Activity Insights
Allos Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allos Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allos Pharma.
Allos Pharma Tech Stack
A closer look at the technologies used by Allos Pharma
Allos Pharma News & Media
Allos Pharma Inc. Receives FDA Guidance for the Design of a Phase 3 Trial to Support a New Drug Application for Treatment of Fragile X Syndrome
CAMBRIDGE, Mass., May 23, 2023 /PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders, announced today that it has held a meeting with the U.S. Food and Drug Administration (FDA) to optimize...Allos Pharma Inc. presents new positive data analyses at the 18th NFXF International Fragile X Conference
CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- Allos Pharma Inc ("Allos"), a late-stage pharmaceutical company developing therapeutics for neurodevelopmental disorders, announces presentation of "Arbaclofen produces clinically meaningful improvements in individuals with Fragile X" at the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allos Pharma
Sign Up For FreeTo access detailed company insights
Allos Pharma is a late-stage pharmaceutical company focused on developing targeted therapeutics for Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). Their lead product, arbaclofen, aims to correct the underlying molecular pathophysiology of these neurodevelopmental disorders, demonstrating clinically meaningful improvements in social fu... Read More
